We are international
Donate
• myeloma tv TEXT SIZE   

'This is the most exciting ASH meeting that I've been to, and I've been a member for over 25 years.'
Morie Gertz, MD
Mayo Clinic

The IMF is pleased to provide you with a broad sampling of myeloma presentations and posters from the 2008 annual meeting of the American Society of Hematology in San Francisco, California. We hope you will find this material informative and useful.

 print    
ASH 2008 WEBCASTS

NEWLY-DIAGNOSED: TRANSPLANT ELIGIBLE
01.04.09   Dr. Kumar - Safety and Efficacy of Novel Combination Therapy with Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide in Newly Diagnosed Multiple Myeloma: Initial Results from the Phase I/II Multi-Center EVOLUTION Study
Shaji Kumar, MD
Mayo Clinic
Rochester, Minnesota
USA

01.04.09   Dr. San Miguel - Updated Follow-up and Results of Subsequent Therapy in the Phase III VISTA Trial: Bortezomib Plus Melphalan–Prednisone Versus Melphalan–Prednisone in Newly Diagnosed Multiple Myeloma
Jesús San Miguel, MD
Hospital Clinico Universitario
Universidad de Salamanca
Salamanca, Spain
Member, IMF Board of Scientific Advisors

01.04.09   Dr. Sonneveld - First Analysis of HOVON-65/GMMG-HD4 Randomized Phase III Trial Comparing Bortezomib, Adriamycine, Dexamethasone (PAD) Vs VAD as Induction Treatment Prior to High Dose Melphalan (HDM) in Patients with Newly Diagnosed Multiple Myeloma (MM)
Pieter Sonneveld, MD, PhD
Erasmus Medical Center
Rotterdam, Netherlands
Member, IMF Board of Scientific Advisors

STEM CELL TRANSPLANT
01.04.09   Dr. Avigan - Fusion Cell Vaccination in Conjunction with Stem Cell Transplantation Is Well Tolerated, Induces Anti-Tumor Immunity and Is Associated with Responses in Patients with Multiple Myeloma
David Avigan, MD
Beth Israel Deaconess Medical Center
Boston Massachusetts
USA

NEW AGENTS
01.04.09   Dr. Kaufman - ASH 2008 - First Trial of Humanized Anti-CD74 Monoclonal Antibody (MAb), Milatuzumab, in Multiple Myeloma
Jonathan Kaufman, MD
Emory University School of Medicine
Winship Cancer Institute
Atlanta Georgia
USA

ALSO OF INTEREST
01.20.09   Multiple Myeloma: Finding Your Way Through the Treatment Maze - Selecting the Best Treatment in the Era of Novel Agents
Audiocast of the IMF Super Friday Program at the 50th ASH Annual Meeting and Exposition